Summary:
- This article discusses how Bayer, a major pharmaceutical company, is focusing on growing its pharmaceutical business by investing in high-value drugs and treatments.
- Bayer is aiming to accelerate the growth of its pharmaceutical division by launching new products and expanding its portfolio of innovative medicines.
- The company is particularly interested in developing drugs and therapies for areas such as cardiovascular, oncology, and women's health, which have significant potential for growth and impact.